Has Nathan Johnson received payments from drug or device companies?

Yes. Drug and device makers reported $465 in general payments to Nathan Johnson across 25 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nathan Johnson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nathan Johnson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nathan Johnson

Family · Redford, MINPI 1063024891

Payments from drug & device makers

$465in general payments, 2019–2025

Across 25 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Indivior Inc.$121
Otsuka America Pharmaceutical, Inc.$69
Alkermes, Inc.$51
E.r. Squibb & Sons, L.L.C.$46
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$45
Johnson & Johnson$37
plus $97 from 4 others

What the payments were for

Food & beverage$465100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Indivior Inc.	7	$121
Otsuka America Pharmaceutical, Inc.	4	$69
Alkermes, Inc.	2	$51
E.r. Squibb & Sons, L.L.C.	2	$46
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$45
Johnson & Johnson	2	$37
Axsome Therapeutics, Inc.	2	$32
Ironshore Pharmaceuticals Inc.	2	$27
Vanda Pharmaceuticals Inc.	1	$23
Neurocrine Biosciences, Inc.	1	$15

How this compares

$465 in reported general payments places this provider in the 55th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan →

Medicare billing

Part B allowed, 2024

$5,086

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
TrulicityDulaglutide	13	$12,427
JanumetSitagliptin Phos/Metformin Hcl	16	$7,237
MyrbetriqMirabegron	15	$7,071
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	14	$6,530
Ventolin HfaAlbuterol Sulfate	45	$2,716
Albuterol Sulfate HfaAlbuterol Sulfate	49	$1,279
Atorvastatin Calcium	117	$812
Memantine Hcl	13	$618
Diclofenac Sodium	23	$579
Amlodipine Besylate	126	$514
Oxybutynin Chloride ErOxybutynin Chloride	15	$482
Simvastatin	87	$397
Levothyroxine Sodium	34	$392
Metoprolol Succinate	44	$386
Omeprazole	54	$362

Paid to pharmacies, not to this prescriber.

Other family in Redford

Jayme HeimGrandville$663K
Susan WolgamottBloomfield Township$327K
Elisheva EllenbergDetroit$150K
Sarah JohnsonFarmington Hills$119K
Daniela MaximTroy$112K
Kelsey PrinceGrand Rapids$87K
Brent MillerFremont$66K
Rachael CompeauFlint$62K
David KocendaLapeer$49K
Tracy RobertsonBay City$47K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →